https://www.selleckchem.com/pr....oducts/geneticin-g41
When SARS-CoV-2 emerged at the end of 2019, no approved therapeutics or vaccines were available. #link# An urgent need for countermeasures during this crisis challenges the current paradigm of traditional drug discovery and development, which usually takes years from start to finish. Approaches that accelerate this process need to be considered. Here we propose the minimum data package required to move a compound into clinical development safely. We further define the additional data that should be collected in parallel w
Like
Comment
Share
